Science & Technology
Novel strategy to block AAV neutralizing antibody activity
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R42TR004338-02
Award Ceiling
$994K
Award Floor
$994K
Close Date
Aug 31, 2028
900 days leftTotal Funding
$994K
Expected Awards
1
Posted Date
Aug 15, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2R42TR004338-02
Description
STTR Phase Phase II award: "Novel strategy to block AAV neutralizing antibody activity" awarded to NABGEN INC in DURHAM, North Carolina. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $993,865. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.